Ireland as a Biologics Hub
Ireland is one of the most concentrated biologics manufacturing ecosystems globally. The country hosts multiple large-scale sterile facilities supplying EU and US markets. This creates a highly mature but capacity-constrained operating environment.
Brownfield Expansion Complexity
Unlike greenfield builds, brownfield expansions must protect live production. Key constraints included:
- Maintaining validated cleanroom classifications
- Avoiding utility downtime (WFI, clean steam)
- Protecting batch continuity
- Working around live GMP operations
Regulatory Landscape
- EU GMP Annex 1 (Sterile Manufacturing)
- FDA 21 CFR Part 210/211
- HPRA inspection scheduling
- QP batch release accountability
The regulatory window was fixed. Inspection delay would directly defer commercial supply.